C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
Heart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriure...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2020-11-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.139910 |
id |
doaj-bc488a37aaa24a19ac2437a35f753e5f |
---|---|
record_format |
Article |
spelling |
doaj-bc488a37aaa24a19ac2437a35f753e5f2021-08-02T20:49:32ZengAmerican Society for Clinical investigationJCI Insight2379-37082020-11-01522C-type natriuretic peptide moderates titin-based cardiomyocyte stiffnessKonstanze MichelMelissa HerwigFranziska WernerKatarina Špiranec SpesMarco AbeßerKai SchuhSwati DabralAndreas MüggeHideo A. BabaBoris V. SkryabinNazha HamdaniMichaela KuhnHeart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriuretic peptide (CNP), via its guanylyl cyclase-B (GC-B) receptor and cGMP/PKGI signaling, modulates titin-based ventricular compliance. To dissect GC-B–mediated effects of endogenous CNP in cardiomyocytes, we generated mice with cardiomyocyte-restricted GC-B deletion (CM GC-B–KO mice). The impact on heart morphology and function, myocyte passive tension, and titin isoform expression and phosphorylation was studied at baseline and after increased afterload induced by transverse aortic constriction (TAC). Pressure overload increased left ventricular endothelial CNP expression, with an early peak after 3 days. Concomitantly, titin phosphorylation at Ser4080, the site phosphorylated by PKGI, was augmented. Notably, in CM GC-B–KO mice this titin response was abolished. TAC-induced hypertrophy and fibrosis were not different between genotypes. However, the KO mice presented mild systolic and diastolic dysfunction together with myocyte stiffness, which were not observed in control littermates. In vitro, recombinant PKGI rescued reduced titin-Ser4080 phosphorylation and reverted passive stiffness of GC-B–deficient cardiomyocytes. CNP-induced activation of GC-B/cGMP/PKGI signaling in cardiomyocytes provides a protecting regulatory circuit preventing titin-based myocyte stiffening during early phases of pressure overload.https://doi.org/10.1172/jci.insight.139910Cardiology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Konstanze Michel Melissa Herwig Franziska Werner Katarina Špiranec Spes Marco Abeßer Kai Schuh Swati Dabral Andreas Mügge Hideo A. Baba Boris V. Skryabin Nazha Hamdani Michaela Kuhn |
spellingShingle |
Konstanze Michel Melissa Herwig Franziska Werner Katarina Špiranec Spes Marco Abeßer Kai Schuh Swati Dabral Andreas Mügge Hideo A. Baba Boris V. Skryabin Nazha Hamdani Michaela Kuhn C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness JCI Insight Cardiology |
author_facet |
Konstanze Michel Melissa Herwig Franziska Werner Katarina Špiranec Spes Marco Abeßer Kai Schuh Swati Dabral Andreas Mügge Hideo A. Baba Boris V. Skryabin Nazha Hamdani Michaela Kuhn |
author_sort |
Konstanze Michel |
title |
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
title_short |
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
title_full |
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
title_fullStr |
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
title_full_unstemmed |
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
title_sort |
c-type natriuretic peptide moderates titin-based cardiomyocyte stiffness |
publisher |
American Society for Clinical investigation |
series |
JCI Insight |
issn |
2379-3708 |
publishDate |
2020-11-01 |
description |
Heart failure is often accompanied by titin-dependent myocardial stiffness. Phosphorylation of titin by cGMP-dependent protein kinase I (PKGI) increases cardiomyocyte distensibility. The upstream pathways stimulating PKGI-mediated titin phosphorylation are unclear. We studied whether C-type natriuretic peptide (CNP), via its guanylyl cyclase-B (GC-B) receptor and cGMP/PKGI signaling, modulates titin-based ventricular compliance. To dissect GC-B–mediated effects of endogenous CNP in cardiomyocytes, we generated mice with cardiomyocyte-restricted GC-B deletion (CM GC-B–KO mice). The impact on heart morphology and function, myocyte passive tension, and titin isoform expression and phosphorylation was studied at baseline and after increased afterload induced by transverse aortic constriction (TAC). Pressure overload increased left ventricular endothelial CNP expression, with an early peak after 3 days. Concomitantly, titin phosphorylation at Ser4080, the site phosphorylated by PKGI, was augmented. Notably, in CM GC-B–KO mice this titin response was abolished. TAC-induced hypertrophy and fibrosis were not different between genotypes. However, the KO mice presented mild systolic and diastolic dysfunction together with myocyte stiffness, which were not observed in control littermates. In vitro, recombinant PKGI rescued reduced titin-Ser4080 phosphorylation and reverted passive stiffness of GC-B–deficient cardiomyocytes. CNP-induced activation of GC-B/cGMP/PKGI signaling in cardiomyocytes provides a protecting regulatory circuit preventing titin-based myocyte stiffening during early phases of pressure overload. |
topic |
Cardiology |
url |
https://doi.org/10.1172/jci.insight.139910 |
work_keys_str_mv |
AT konstanzemichel ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT melissaherwig ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT franziskawerner ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT katarinaspiranecspes ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT marcoabeßer ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT kaischuh ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT swatidabral ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT andreasmugge ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT hideoababa ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT borisvskryabin ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT nazhahamdani ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness AT michaelakuhn ctypenatriureticpeptidemoderatestitinbasedcardiomyocytestiffness |
_version_ |
1721227094888808448 |